E1	Condition:T1 Name:T2 Severity:T75 Duration:E18
E3	Procedure:T3 Name:T4
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8 Temporality:E28
E9	Condition:T9 Name:T10 Temporality:E41
E11	Procedure:T11 Name:T12 Temporality:E30
E13	Condition:T13 Name:T14 Severity:T145
E15	Condition:T15 Name:T16
E18	Eq-Comparison:T50 Operator:T19 Value:T40 Temporal-Unit:T76
E19	Eq-Comparison:T51 Operator:T23 Value:T41 Temporal-Unit:T116
E20	Eq-Comparison:T52 Operator:T25 Unit:T37 Value:T42
E21	Eq-Comparison:T53 Operator:T26 Unit:T38 Value:T43
E22	Eq-Comparison:T54 Operator:T27 Value:T44
E23	Eq-Comparison:T55 Operator:T28 Value:T45 Unit:T128 Per:T129
E24	Eq-Comparison:T56 Operator:T29 Value:T46
E25	Eq-Comparison:T57 Operator:T30 Value:T47 Temporal-Unit:T139
E26	Eq-Comparison:T58 Operator:T31 Value:T48 Per:T39
E27	Eq-Comparison:T59 Operator:T32 Value:T49 Temporal-Unit:T150
E28	Eq-Comparison:T60 Temporal-Period:T61 Value:T87 Temporal-Unit:T33
E29	Eq-Comparison:T62 Temporal-Period:T63 Value:T92 Temporal-Unit:T34
E30	Eq-Comparison:T64 Temporal-Period:T65 Operator:T21 Value:T104 Temporal-Unit:T36
E31	Eq-Comparison:T66 Temporal-Period:T67
E33	Eq-Comparison:T70 Temporal-Period:T71
E2	Study:T72
E4	Assertion:T73 Asserted:E2
E6	Assertion:T74 Asserted:E1
E8	Procedure:T77
E10	Modifier:T78 Modifies:T4
E12	Drug:T79 Name:T80
E14	Drug:T81 Name:T82
E16	Condition:T83 Name:T84 Temporality:E34
E34	Eq-Comparison:T85 Temporal-Period:T86
E35	Condition:T88 Name:T89 Severity:T91 Temporality:E29
E36	Modifier:T90 Modifies:T89
E37	Modifier:T93 Modifies:T10
E38	Modifier:T94 Modifies:T10
E39	Modifier:T95 Modifies:T10
E40	Or:T96 Arg:E38 Arg2:E37
E41	Eq-Comparison:T97 Operator:T20 Value:T98 Temporal-Unit:T35
E42	Condition:T99 Name:T100 Severity:T101
E43	Modifier:T102 Modifies:T12
E44	Or:T103 Arg:E42 Arg2:E11
E45	Condition:T105 Name:T106 Temporality:E50
E46	Modifier:T107 Modifies:T106
E47	Modifier:T108 Modifies:T106
E48	Or:T109 Arg:E47 Arg2:E46
E49	Modifier:T110 Modifies:T106
E50	Eq-Comparison:T111 Operator:T22 Temporal-Unit:T113 Value:T112
E51	Drug:T114 Name:T115 Temporality:E33 Temporality2:E19
E52	Observation:T117 Name:T118 Eq-Comparison:E53
E53	Eq-Comparison:T119 Operator:T24 Unit:T120
E54	Observation:T121 Name:T122 Eq-Comparison:E20
E55	Observation:T123 Name:T124 Eq-Comparison:E21
E56	Or:T125 Arg:E54 Arg2:E55
E57	Observation:T126 Name:T127 Eq-Comparison:E22
E58	Or:T130 Arg:E22 Arg2:E23
E59	Drug:T131 Name:T132 Temporality:E31
E60	Observation:T133 Name:T134 Eq-Comparison:E24
E61	And:T135 Arg:E59 Arg2:E60
E62	Observation:T136 Name:T137 Eq-Comparison:E25
E63	Or:T138 Arg:E60 Arg2:E62
E64	Observation:T140 Name:T141 Eq-Comparison:E26
E17	Modifier:T17 Modifies:T14
E65	Other:T18 Is-Other:E17
E66	Modifier:T142 Modifies:T14
E67	Modifier:T143 Modifies:T14
E68	Modifier:T144 Modifies:T14
E69	Or:T146 Arg:E66 Arg2:E17
E70	Allergy:T147 Name:E32
E32	Drug:T68 Name:T69
E71	Eq-Comparison:T148 Temporal-Recency:T149
E72	Condition:T151 Name:T152 Temporality:E71
E73	Temporal-Connection:T153 Arg:E27 Arg2:E71
E74	Observation:T154 Name:T155
E75	Negation:T156 Negates:E74
E76	Encounter:T157 Type:T158
E77	Temporal-Connection:T159 Arg:E75 Arg2:E76
E78	Study:T160
E79	Negation:T161 Negates:E78
T1	Condition 134 132	ischemic stroke
T2	Condition-Name 134 132	ischemic stroke
T3	Procedure 242 237	thrombolytic therapy
T4	Procedure-Name 242 237	thrombolytic therapy
T5	Condition 428 409	acute myocardial infarction
T6	Condition-Name 428 409	acute myocardial infarction
T7	Condition 453 433	cerebrovascular stroke
T8	Condition-Name 453 433	cerebrovascular stroke
T9	Condition 601 575	hemorrhage
T10	Condition-Name 601 575	hemorrhage
T11	Procedure 664 636	surgery
T12	Procedure-Name 664 636	surgery
T13	Condition 1261 1199	dysfunction
T14	Condition-Name 1261 1199	dysfunction
T15	Condition 1203 1143	pregnancy
T16	Condition-Name 1203 1143	pregnancy
T19	Eq-Operator 152 150	≤
T20	Eq-Operator 608 582	within
T21	Eq-Operator 671 643	within
T22	Eq-Operator 766 734	within
T23	Eq-Operator 813 779	within
T24	Eq-Operator 892 856	greater than
T25	Eq-Operator 946 908	>
T26	Eq-Operator 980 941	>
T27	Eq-Operator 1014 972	<
T28	Eq-Operator 1023 979	>
T29	Eq-Operator 1115 1066	>
T30	Eq-Operator 1142 1091	>
T31	Eq-Operator 1168 1115	<
T32	Eq-Operator 1327 1261	>
T33	Eq-Temporal-Unit 482 462	months
T34	Eq-Temporal-Unit 539 517	months
T35	Eq-Temporal-Unit 624 598	weeks
T36	Eq-Temporal-Unit 694 666	weeks
T37	Eq-Unit 956 917	mmHg
T38	Eq-Unit 990 950	mmHg
T39	Eq-Unit 1186 1127	mm3
T40	Eq-Value 157 154	4.5
T41	Eq-Value 817 782	48
T42	Eq-Value 951 912	185
T43	Eq-Value 985 945	110
T44	Eq-Value 1018 974	50
T45	Eq-Value 1028 983	400
T46	Eq-Value 1120 1070	1.7
T47	Eq-Value 1146 1093	15
T48	Eq-Value 1179 1123	100,000
T49	Eq-Value 1332 1265	4.5
T50	Eq-Comparison 163 160	≤ 4.5 hours
T51	Eq-Comparison 823 788	within 48 hours
T52	Eq-Comparison 956 917	> 185 mmHg
T53	Eq-Comparison 990 950	> 110 mmHg
T54	Eq-Comparison 1018 974	<50
T55	Eq-Comparison 1036 989	> 400 mg/dL
T56	Eq-Comparison 1120 1070	> 1.7
T57	Eq-Comparison 1150 1097	>15 sec
T58	Eq-Comparison 1186 1127	< 100,000/mm3
T59	Eq-Comparison 1338 1271	> 4.5 hours
T60	Eq-Comparison 482 462	previous three months
T61	Eq-Temporal-Period 469 449	previous
T62	Eq-Comparison 539 517	previous three months
T63	Eq-Temporal-Period 526 504	previous
T64	Eq-Comparison 694 666	within the previous two weeks
T65	Eq-Temporal-Period 684 656	previous
T66	Eq-Comparison 1056 1007	current use
T67	Eq-Temporal-Period 1056 1007	current use
T70	Eq-Comparison 798 764	received
T71	Eq-Temporal-Period 798 764	received
T72	Study 80 78	study
T73	Assertion 57 55	eligible for
T74	Assertion 112 110	suggesting
T75	Severity 118 116	acute
T76	Eq-Temporal-Unit 163 160	hours
T77	Procedure 204 199	treated
T78	Modifier 221 216	intravenous
T79	Drug 288 280	recombinant tissue plasminogen activator
T80	Drug-Name 288 280	recombinant tissue plasminogen activator
T81	Drug 298 287	rt-PA
T82	Drug-Name 298 287	rt-PA
T83	Condition 367 348	hemorrhagic stroke
T84	Condition-Name 367 348	hemorrhagic stroke
T85	Eq-Comparison 348 329	had
T86	Eq-Temporal-Period 348 329	had
T87	Eq-Value 475 455	three
T88	Condition 510 488	trauma
T89	Condition-Name 510 488	trauma
T90	Modifier 503 481	head
T91	Severity 498 476	serious
T92	Eq-Value 532 510	three
T93	Modifier 590 564	gastrointestinal
T94	Modifier 568 543	lung
T95	Modifier 561 537	urinary tract
T96	Or 573 547	or
T97	Eq-Comparison 624 598	within the three weeks
T98	Eq-Value 618 592	three
T99	Condition 647 619	trauma
T100	Condition-Name 647 619	trauma
T101	Severity 640 612	serious
T102	Modifier 656 628	major
T103	Or 650 622	or
T104	Eq-Value 688 660	two
T105	Condition 730 700	puncture
T106	Condition-Name 730 700	puncture
T107	Modifier 721 691	arterial
T108	Modifier 709 679	lumbar
T109	Or 712 682	or
T110	Modifier 759 727	non-compressible site
T111	Eq-Comparison 775 743	within one week
T112	Eq-Value 770 738	one
T113	Eq-Temporal-Unit 775 743	week
T114	Drug 806 772	heparin
T115	Drug-Name 806 772	heparin
T116	Eq-Temporal-Unit 823 788	hours
T117	Observation 879 843	activated partial thromboplastin time
T118	Observation-Name 879 843	activated partial thromboplastin time
T119	Eq-Comparison 918 882	greater than the upper limit of normal
T120	Eq-Unit 918 882	upper limit of normal
T121	Observation 944 906	systolic pressure
T122	Observation-Name 944 906	systolic pressure
T123	Observation 978 939	diastolic pressure
T124	Observation-Name 978 939	diastolic pressure
T125	Or 959 920	or
T126	Observation 1012 970	blood glucose
T127	Observation-Name 1012 970	blood glucose
T128	Eq-Unit 1031 986	mg
T129	Eq-Unit 1036 989	dL
T130	Or 1021 977	or
T131	Drug 1074 1025	anticoagulants
T132	Drug-Name 1074 1025	anticoagulants
T133	Observation 1113 1064	International Normalized Ratio
T134	Observation-Name 1113 1064	International Normalized Ratio
T135	And 1079 1030	with
T136	Observation 1140 1090	prothrombin time
T137	Observation-Name 1140 1090	prothrombin time
T138	Or 1123 1073	or
T139	Eq-Temporal-Unit 1150 1097	sec
T140	Observation 1166 1113	platelet count
T141	Observation-Name 1166 1113	platelet count
T17	Modifier 1249 1187	organ
T18	Other 1243 1181	other
T142	Modifier 1234 1172	kidney
T143	Modifier 1225 1164	lung
T144	Modifier 1218 1158	heart
T145	Severity 1212 1152	serious
T146	Or 1237 1175	or
T147	Allergy 1277 1213	allergy
T68	Drug 1310 1244	rt-PA
T69	Drug-Name 1310 1244	rt-PA
T148	Eq-Comparison 1357 1290	last time
T149	Eq-Temporal-Recency 1357 1290	last time
T150	Eq-Temporal-Unit 1338 1271	hours
T151	Condition 1382 1315	asymptomatic
T152	Condition-Name 1382 1315	asymptomatic
T153	Temporal-Connection 1343 1276	from
T154	Observation 1413 1344	troponin
T155	Observation-Name 1413 1344	troponin
T156	Negation 1421 1352	not
T157	Encounter 1443 1374	admission
T158	Encounter-Type 1443 1374	admission
T159	Temporal-Connection 1433 1364	at
T160	Study 1472 1403	study
T161	Negation 1457 1388	excluded
A1	Eq-Operator-Value T19 LTEQ
A2	Eq-Operator-Value T20 LTEQ
A3	Eq-Operator-Value T21 LTEQ
A4	Eq-Operator-Value T22 LTEQ
A5	Eq-Operator-Value T23 LTEQ
A6	Eq-Operator-Value T24 GT
A7	Eq-Operator-Value T25 GT
A8	Eq-Operator-Value T26 GT
A9	Eq-Operator-Value T27 LT
A10	Eq-Operator-Value T28 GT
A11	Eq-Operator-Value T29 GT
A12	Eq-Operator-Value T30 GT
A13	Eq-Operator-Value T31 LT
A14	Eq-Operator-Value T32 GT
A15	Eq-Temporal-Unit-Value T33 month
A16	Eq-Temporal-Unit-Value T34 month
A17	Eq-Temporal-Unit-Value T35 week
A18	Eq-Temporal-Unit-Value T36 week
A19	Eq-Temporal-Period-Value T61 past
A20	Eq-Temporal-Period-Value T63 past
A21	Eq-Temporal-Period-Value T65 past
A22	Eq-Temporal-Period-Value T67 present
A24	Eq-Temporal-Period-Value T71 past
A25	Assertion-Type-Value E4 hypothetical
A26	Assertion-Type-Value E6 possible
A27	Severity-Value T75 severe
A28	Eq-Temporal-Unit-Value T76 hour
A29	Eq-Temporal-Period-Value T86 past
A30	Severity-Value T91 severe
A31	Severity-Value T101 severe
A32	Eq-Temporal-Unit-Value T113 week
A33	Eq-Temporal-Unit-Value T116 hour
A34	Observation-Type-Value T118 measurement
A35	Eq-Unit-Value T120 ref-range-high
A36	Observation-Type-Value T122 vital
A37	Observation-Type-Value T124 vital
A38	Observation-Type-Value T127 lab
A39	Observation-Type-Value T134 measurement
A40	Observation-Type-Value T137 lab
A41	Eq-Temporal-Unit-Value T139 second
A42	Observation-Type-Value T141 lab
A43	Severity-Value T145 severe
A23	Eq-Temporal-Recency-Value T149 most-recent-time
A44	Eq-Temporal-Unit-Value T150 hour
A45	Temporal-Connection-Type-Value E73 after
A46	Observation-Type-Value T155 lab
A47	Encounter-Type-Value T158 inpatient
A48	Temporal-Connection-Type-Value E77 during
R1	If-Then Arg1:E1 Arg2:E2
R2	Using Arg1:E8 Arg2:E3
R3	Abbrev-Of Arg1:E14 Arg2:E12
R4	Equivalent-To Arg1:E12 Arg2:E3
R5	Caused-By Arg1:E52 Arg2:E51
R6	If-Then Arg1:E76 Arg2:E79